Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography.

Plasma levels of high density lipoprotein cholesterol (HDL-C) are inversely proportional to the incidence of cardiovascular disease. Recent applications of modern proteomic technologies have identified upward of 50 distinct proteins associated with HDL particles with many of these newly discovered proteins implicating HDL in nonlipid transport processes including complement activation, acute phase response and innate immunity. However, almost all MS-based proteomic studies on HDL to date have utilized density gradient ultracentrifugation techniques for HDL isolation prior to analysis. These involve high shear forces and salt concentrations that can disrupt HDL protein interactions and alter particle function. Here, we used high-resolution size exclusion chromatography to fractionate normal human plasma to 17 phospholipid-containing subfractions. Then, using a phospholipid binding resin, we identified proteins that associate with lipoproteins of various sizes by electrospray ionization mass spectrometry. We identified 14 new phospholipid-associated proteins that migrate with traditionally defined HDL, several of which further support roles for HDL in complement regulation and protease inhibition. The increased fractionation inherent to this method allowed us to visualize HDL protein distribution across particle size with unprecedented resolution. The observed heterogeneity across subfractions suggests the presence of HDL particle subpopulations each with distinct protein components that may prove to impart distinct physiological functions.

[1]  P. Durrington,et al.  Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein , 1991, FEBS letters.

[2]  A. Scanu,et al.  Serum lipoproteins structure and function. , 1972, Annual review of biochemistry.

[3]  J. Raper,et al.  Activity of trypanosome lytic factor: a novel component of innate immunity. , 2009, Future microbiology.

[4]  D. James,et al.  Pigment epithelium-derived factor contributes to insulin resistance in obesity. , 2009, Cell metabolism.

[5]  Inna Chervoneva,et al.  Differential Expression of Lumican and Fibromodulin Regulate Collagen Fibrillogenesis in Developing Mouse Tendons , 2000, The Journal of cell biology.

[6]  Per Leanderson,et al.  Lipoproteomics II: Mapping of proteins in high‐density lipoprotein using two‐dimensional gel electrophoresis and mass spectrometry , 2005, Proteomics.

[7]  R. Aebersold,et al.  A statistical model for identifying proteins by tandem mass spectrometry. , 2003, Analytical chemistry.

[8]  M. Heller,et al.  Mass spectrometry‐based analytical tools for the molecular protein characterization of human plasma lipoproteins , 2005, Proteomics.

[9]  T. Fujita,et al.  Activation of the lectin complement pathway by ficolins. , 2001, International immunopharmacology.

[10]  M. Young,et al.  A potential role for tetranectin in mineralization during osteogenesis , 1994, The Journal of cell biology.

[11]  G. Franceschini,et al.  Reverse cholesterol transport: physiology and pharmacology. , 1991, Atherosclerosis.

[12]  J. Gamble,et al.  High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[13]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[14]  B. Cham,et al.  A solvent system for delipidation of plasma or serum without protein precipitation. , 1976, Journal of lipid research.

[15]  W. Davidson,et al.  High-Density Lipoprotein Proteomics: Identifying New Drug Targets and Biomarkers by Understanding Functionality , 2010, Current cardiovascular risk reports.

[16]  Subramaniam Pennathur,et al.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. , 2007, The Journal of clinical investigation.

[17]  M. Plotnick,et al.  The Effects of Reactive Site Location on the Inhibitory Properties of the Serpin α1-Antichymotrypsin* , 2002, The Journal of Biological Chemistry.

[18]  O. Quehenberger,et al.  Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages. , 1989, Arteriosclerosis.

[19]  D. Rader,et al.  The Role of High Density Lipoproteins in Thrombosis , 2002, TheScientificWorldJournal.

[20]  H. V. van Duyvenvoorde,et al.  Human Acid-Labile Subunit Deficiency: Clinical, Endocrine and Metabolic Consequences , 2009, Hormone Research in Paediatrics.

[21]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[22]  J. Gwynne,et al.  The role of high density lipoproteins in rat adrenal cholesterol metabolism and steroidogenesis. , 1980, The Journal of biological chemistry.

[23]  A. Quantock,et al.  An x-ray diffraction investigation of corneal structure in lumican-deficient mice. , 2001, Investigative ophthalmology & visual science.

[24]  B. Fagerberg,et al.  Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[25]  R. Baxter,et al.  Insulin-like Growth Factor-binding Protein 5 Complexes with the Acid-labile Subunit , 1998, The Journal of Biological Chemistry.

[26]  Mitsuyo Okazaki,et al.  A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. , 2002, Journal of lipid research.

[27]  F. V. van’t Hooft,et al.  Metabolism of apolipoprotein E in plasma high density lipoproteins from normal and cholesterol-fed rats. , 1982, The Journal of biological chemistry.

[28]  M. Olivier,et al.  Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry. , 2010, Physiological genomics.

[29]  T. Vaisar,et al.  Pathways for oxidation of high-density lipoprotein in human cardiovascular disease. , 2006, Current opinion in molecular therapeutics.

[30]  Alexey I Nesvizhskii,et al.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. , 2002, Analytical chemistry.

[31]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[32]  W. Garner,et al.  Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1-antichymotrypsin. , 2008, The Journal of investigative dermatology.

[33]  A. Tenner Functional aspects of the C1q receptors. , 1993, Behring Institute Mitteilungen.

[34]  A. Kontush,et al.  Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters: Relevance to Antioxidative Function , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[35]  E. Alberdi,et al.  Pigment epithelium‐derived factor promotes the survival and differentiation of developing spinal motor neurons , 1999, The Journal of comparative neurology.

[36]  D. Shih,et al.  Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis , 1998, Nature.

[37]  S. Lorkowski,et al.  HDL-Associated Lysosphingolipids Inhibit NAD(P)H Oxidase–Dependent Monocyte Chemoattractant Protein-1 Production , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[38]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.